Published in Curr Med Chem on September 01, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med (2009) 12.73
CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol (2005) 1.83
CCR7 deficiency exacerbates injury in acute nephritis due to aberrant localization of regulatory T cells. J Am Soc Nephrol (2009) 1.79
IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol (2010) 1.52
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell (2008) 1.49
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study. Wien Klin Wochenschr (2002) 1.39
A rare case of milky urine. Wien Klin Wochenschr (2010) 1.39
Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy. Am J Kidney Dis (2002) 1.39
Renal involvement in autoimmune connective tissue diseases. BMC Med (2013) 1.21
Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur J Immunol (2005) 1.16
Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest (2009) 1.16
Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol (2007) 1.08
A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clin J Am Soc Nephrol (2009) 1.07
Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol Renal Physiol (2007) 1.05
Computer modeling of siRNA knockdown effects indicates an essential role of the Ca2+ channel alpha2delta-1 subunit in cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2007) 1.05
Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review. Am J Nephrol (2014) 1.01
Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest (2004) 1.01
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int (2003) 1.01
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Recipient and donor body mass index as important risk factors for delayed kidney graft function. Transplantation (2012) 0.98
The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur J Immunol (2005) 0.98
Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients. Nephrol Dial Transplant (2010) 0.96
Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics (2009) 0.96
[Remission of chronic kidney diseases. A realistic goal?]. Wien Klin Wochenschr (2003) 0.96
Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis. Kidney Int (2009) 0.95
Reliability of t7-based mRNA linear amplification validated by gene expression analysis of human kidney cells using cDNA microarrays. Nephron Exp Nephrol (2004) 0.94
Role of alpha/beta and gamma/delta T cells in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2007) 0.93
Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol Dial Transplant (2007) 0.93
Eurotransplant kidney allocation system (ETKAS): rationale and implementation. Nephrol Dial Transplant (2005) 0.93
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation (2007) 0.93
Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant (2004) 0.92
The role of auxiliary dihydropyridine receptor subunits in muscle. J Muscle Res Cell Motil (2005) 0.92
Risk factors for peritoneal dialysis-associated peritonitis: the role of oral active vitamin d. Perit Dial Int (2010) 0.91
Effect of tissue fixatives on telomere length determination by quantitative PCR. Mech Ageing Dev (2005) 0.91
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy. Proteomics Clin Appl (2011) 0.90
Transforming omics data into context: bioinformatics on genomics and proteomics raw data. Electrophoresis (2006) 0.90
Bortezomib-induced survival signals and genes in human proximal tubular cells. J Pharmacol Exp Ther (2008) 0.89
Regional variability in the incidence of end-stage renal disease: an epidemiological approach. Nephrol Dial Transplant (2003) 0.88
p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2006) 0.88
Pharmacokinetic analysis of docetaxel during haemodialysis in a patient with locally advanced non-small cell lung cancer. Nephrol Dial Transplant (2006) 0.87
Differential effects of rapamycin in anti-GBM glomerulonephritis. J Am Soc Nephrol (2008) 0.86
Oncostatin M is a novel inhibitor of TGF-β1-induced matricellular protein expression. Am J Physiol Renal Physiol (2011) 0.86
Age and renal transplantation: an interim analysis. Nephrol Dial Transplant (2003) 0.86
Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease. BMC Nephrol (2014) 0.85
Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells. Lab Invest (2009) 0.85
Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report. Medicine (Baltimore) (2014) 0.85
SRP-27 is a novel component of the supramolecular signalling complex involved in skeletal muscle excitation-contraction coupling. Biochem J (2008) 0.84
The proteasome inhibitor bortezomib aggravates renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2009) 0.84
Cigarette smoking and vascular pathology in renal biopsies. Kidney Int (2002) 0.84
Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells. Biochem Biophys Res Commun (2012) 0.83
Cigarette smoking and chronic allograft nephropathy. Nephrol Dial Transplant (2007) 0.83
Late referral defined by renal function: association with morbidity and mortality. J Nephrol (2004) 0.83
Detection of coregulation in differential gene expression profiles. Biosystems (2005) 0.83
Regular physical exercise improves endothelial function in heart transplant recipients. Clin Transplant (2002) 0.83
Discrete simulation of regulatory homo- and heterodimerization in the apoptosis effector phase. Bioinformatics (2002) 0.82
Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients. Cancer Immunol Immunother (2005) 0.82
Increased renal versican expression is associated with progression of chronic kidney disease. PLoS One (2012) 0.82
Effect of dialysate temperature and diabetes on autonomic cardiovascular regulation during hemodialysis. Kidney Blood Press Res (2008) 0.82
Linking transcriptomic and proteomic data on the level of protein interaction networks. Electrophoresis (2010) 0.82
Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release. Kidney Int (2002) 0.82
Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism. Transplantation (2011) 0.82
Neutrophil transmigration in renal proximal tubular LLC-PK1 cells. Cell Physiol Biochem (2004) 0.82
Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases. Wien Klin Wochenschr (2013) 0.82
Molecular pathways and crosstalk characterizing the cardiorenal syndrome. OMICS (2012) 0.81
Systems biology: building a useful model from multiple markers and profiles. Nephrol Dial Transplant (2012) 0.81
Effect of different immunosuppressive drugs on immune cells from young and old healthy persons. Gerontology (2014) 0.80
The selective mineralocorticoid receptor antagonist eplerenone is protective in mild anti-GBM glomeru-lonephritis. Int J Clin Exp Pathol (2011) 0.80
In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression. Nephrol Dial Transplant (2004) 0.80
Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis. J Nephrol (2004) 0.80
Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system. Nephrol Dial Transplant (2004) 0.80
The exchangeable calcium pool: physiology and pathophysiology in chronic kidney disease. Nephrol Dial Transplant (2011) 0.80
Failure of BCL-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest (2002) 0.79
FGF23 is associated with disease severity and prognosis in chronic heart failure. Eur J Clin Invest (2014) 0.79
Calcineurin inhibitor-based immunosuppressive therapy, donor age, and long-term outcome after kidney transplantation. Transplantation (2009) 0.79
Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Invest (2015) 0.79
Interleukin-19 as a translational indicator of renal injury. Arch Toxicol (2014) 0.79
Sevelamer use and incidence of peritonitis in peritoneal dialysis. Wien Klin Wochenschr (2011) 0.78
Membranous nephropathy in a patient with hereditary complete complement C4 deficiency. Nephrol Dial Transplant (2004) 0.78
ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells. J Cell Physiol (2007) 0.78
Expression of granzyme A in human polymorphonuclear neutrophils. Immunology (2007) 0.77
A murine model of phosphate nephropathy. Am J Pathol (2011) 0.77
Effects of AT1 and AT2 receptor blockade on angiotensin II induced apoptosis of human renal proximal tubular epithelial cells. Wien Klin Wochenschr (2002) 0.77
Role of thrombospondin-1 in the autologous phase of an accelerated model of anti-glomerular basement membrane glomerulonephritis. Nephron Exp Nephrol (2004) 0.77
Positive and negative spatial priming in schizophrenia. J Clin Exp Neuropsychol (2006) 0.76
Impact of anemia on aortic pulse wave velocity in hemodialysis patients. Kidney Blood Press Res (2009) 0.76
Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases. Transpl Int (2004) 0.76
A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases. BMC Med Genomics (2014) 0.75
Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome. Int J Nephrol (2010) 0.75
Antioxidant therapy in glomerular disease. Wien Klin Wochenschr (2002) 0.75
Bloodstream infection following 217 consecutive systemic-enteric drained pancreas transplants. BMC Infect Dis (2006) 0.75
Distal renal artery stenosis after percutaneous renal denervation leading to renal impairment but normotension. J Clin Hypertens (Greenwich) (2014) 0.75
Chronic allograft failure: a disease we don't understand and can't cure? Nephrol Dial Transplant (2002) 0.75
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. Am J Physiol Renal Physiol (2002) 0.75
A hidden cause of angina pectoris: when ABG analysis is the only helpful diagnostic tool. Int J Cardiol (2005) 0.75
[Primary glomerulonephritis]. Wien Klin Wochenschr (2006) 0.75
Fever of unknown origin in renal transplant patients with tacrolimus. Clin Transplant (2008) 0.75
Medicine based on systematic research, eminence based medicine or common sense medicine--what would you prefer? EDTNA ERCA J (2006) 0.75
One-year growth hormone therapy improves granulocyte function without major effects on nutritional and anthropometric parameters in malnourished hemodialysis patients. Nephron Clin Pract (2003) 0.75
The 9th International Wyeth Transplantation Symposium: "Phases, stages and risk factors-considering new immunosuppressive strategies for renal transplant patients." Foreword. Transplant Proc (2009) 0.75